Observational cohort study of remission induction therapy in Japanese patients with ANCA-associated vasculitis and rapidly progressive glomerulonephritis

Observational cohort study of remission induction therapy in Japanese patients with ANCA-associated vasculitis and rapidly progressive glomerulonephritis - New RemiT-JAV-RPGN

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000005136

Enrollment

250

Registered

2011-03-31

Start date

2011-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ANCA-associated vasculitis and rapidly progressive glomerulonephritis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with newly diagnosed ANCA related vasculitis No previous treatments

Exclusion criteria

Exclusion criteria: Patients with relapse Malignancy Replicating hepatitis B and C

Design outcomes

Primary

Measure	Time frame
Time to remission	—

Secondary

Measure	Time frame
Survival Cause of death Treatment response Relapse Severe infections and risk factor Other adverse events Pathologic analysis in pulmonary limited vasculitis Pathologic analysis in renal limited vasculitis Pathological analysis of renal involvement Radiological analysis of pulmonary involvement Intraclass correlation coefficients of the criteria Identification of candidate biomarker	—

Countries

Japan

Contacts

Public ContactKen-ei Sada

Research Committe of Intractable Vasculitis Syndrome of the MHLW of Japan Secretariat

vas-mhlw@md.okayama-u.ac.jp086-235-7235

Outcome results